Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Current Taxes: 2022-2025

Historic Current Taxes for Sunshine Biopharma (SBFM) over the last 2 years, with Jun 2025 value amounting to $258,158.

  • Sunshine Biopharma's Current Taxes rose 1.25% to $258,158 in Q2 2025 from the same period last year, while for Jun 2025 it was $258,158, marking a year-over-year increase of 1.25%. This contributed to the annual value of $268,276 for FY2024, which is 10.54% down from last year.
  • Latest data reveals that Sunshine Biopharma reported Current Taxes of $258,158 as of Q2 2025, which was up 13.17% from $228,115 recorded in Q1 2025.
  • In the past 5 years, Sunshine Biopharma's Current Taxes ranged from a high of $416,245 in Q1 2023 and a low of $201,541 during Q3 2023.
  • Its 3-year average for Current Taxes is $266,770, with a median of $254,971 in 2024.
  • Data for Sunshine Biopharma's Current Taxes shows a peak YoY increase of 26.51% (in 2024) and a maximum YoY decrease of 38.74% (in 2024) over the last 5 years.
  • Quarterly analysis of 4 years shows Sunshine Biopharma's Current Taxes stood at $373,191 in 2022, then decreased by 19.65% to $299,869 in 2023, then fell by 10.54% to $268,276 in 2024, then climbed by 1.25% to $258,158 in 2025.
  • Its last three reported values are $258,158 in Q2 2025, $228,115 for Q1 2025, and $268,276 during Q4 2024.